ACADIA Pharmaceuticals Inc. vs IAC/Interactivecorp — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.55 (market cap $5.07B), while IAC/Interactivecorp trades at $40.21 (market cap $2.97B). The key difference: ACADIA Pharmaceuticals Inc. is the larger of the two by market cap, and ACADIA Pharmaceuticals Inc. is trading nearer its 52-week high, IAC/Interactivecorp nearer its low. Which is the better fit depends on your goals.
| ACAD | PPLI | |
|---|---|---|
Market Cap | $5.07B | $2.97B |
Sector | Health | Media |
52-Week High | $29.41 | $47.62 |
52-Week Low | $20.06 | $31.52 |
Enterprise Value | $4.19B | $3.28B |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →IAC Inc is an Internet media company with segments that include Angi (47% of total revenue), Dotdash (10%), search (24%), and emerging and other (19%). The firm spun off the narrow-moat dating app provider Match Group in second-quarter 2020 and the no-moat video software provider Vimeo in second-quarter 2021.
Read more on PPLI →